Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Supranuclear Palsy, Progressive 1Spinocerebellar Ataxias 1Spastic Paraplegia, Hereditary 1Obesity 1Neuromuscular Diseases 1Myotonic Dystrophy 1Myasthenia Gravis 1Muscular Dystrophy, Facioscapulohumeral 1Lambert-Eaton Myasthenic Syndrome 1Huntington Disease 1Charcot-Marie-Tooth Disease 1

Interventions

fludarabine 6efgartigimod alfa 6Cyclophosphamide 6ravulizumab 4zilucoplan 2telitacicept 2rozanolixizumab 2Prednisone 2remibrutinib 1iptacopan 1inebilizumab 1bu-zhong-yi-qi-tang 1Walk Test 1Tacrolimus 1Steroids 1Rituximab 1Pyridostigmine Bromide 1Prednisolone 1Mycophenolic Acid 1Diagnostic Self Evaluation 1Cognitive Behavioral Therapy 1Cladribine 1Biomarkers 1Azathioprine 1Alleles 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Myasthenia Gravis × Walk Test × Clear all
NCT07136844 2025-08-22

Acti-Adult

Centre Hospitalier Universitaire de Liege

Phase NA Recruiting
300 enrolled
Other

Charcot-Marie-Tooth Disease, Huntington Disease, Myasthenia Gravis, Myotonic Dystrophy, Neuromuscular Diseases, Obesity, Supranuclear Palsy, Progressive, Spastic Paraplegia, Hereditary, Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Facioscapulohumeral, Spinocerebellar Ataxias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡